Exome sequencing of more than 54,000 individuals with epilepsy revealed genetic links
On Oct. 3, 2024, scientists announced the largest whole-exome sequencing study of epilepsy to date, with more than…
On Oct. 3, 2024, scientists announced the largest whole-exome sequencing study of epilepsy to date, with more than…
On Jun. 7, 2021, the National Institutes of Health announced new findings published in JAMA Neurology that suggested…
On Jul. 31, 2020, the U.S. Food and Drug Administration (FDA) announced it had approved Epidiolex (cannabidiol) [CBD]…
On Jun. 25, 2020, the U.S. Food and Drug Administration (FDA) approved Fintepla (fenfluramine), a Schedule IV controlled…
On Mar. 5, 2020, in a study of epilepsy patients, researchers at the National Institutes of Health (NIH)…
On Jun. 25, 2018, the U.S. Food and Drug Administration (FDA) approved Epidiolex (cannabidiol) [CBD] oral solution for…
On Feb. 3, 2016, OHSU Doernbecher Childrenï¾’s Hospital unveiled a 3-Tesla intraoperative magnetic resonance imaging machine that provides…
On Jan. 19, 2016, the McDonnell Genome Institute at Washington University School of Medicine in St. Louis announced…
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
In 1981, Roger W. Sperry of the California Institute of Technology was awarded the Nobel Prize in Physiology…
In 1970, the term ‘developmental disability’ is introduced in the Developmental Disabilities Services and Facilities construction amendments to…